Active Ingredient: NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE
Proprietary Name: NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 220MG;120MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A211360
Product Number: 001
Approval Date: Jun 1, 2022
Applicant Holder Full Name: AUROBINDO PHARMA LTD
Marketing Status:
Over-the-counter
Patent and Exclusivity Information
